Please assess the completion status of the following clinical trial:

Trial Title: Cardiac Rehabilitation for Patients Receiving Radiation Therapy for Thoracic Cancers

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Pathologically confirmed or radiographically diagnosed non-small cell lung cancer, small cell lung cancer, esophageal cancer, Hodgkin lymphoma, non-Hodgkin lymphoma, sarcoma, thymoma, or left-sided breast cancer.~* Planning to receive neo-adjuvant, adjuvant, or definitive radiation therapy to the thorax with curative intent.~* Willing to participate in home-based cardiac rehabilitation program and be monitored remotely via smart phone application~* Possess a smart phone or tablet capable of supporting teleHeart application~* Willing and eligible to co-enroll in the Cardiovascular Toxicity in Cancer and Improvement in Recovery (SURVIVE) Registry Study (HRPO# 201801031).~* At least 18 years of age.~* ECOG performance status ≤ 2~* Ability to understand and willingness to sign an IRB approved written informed consent document (or that of legally authorized representative, if applicable).~Exclusion Criteria:~* Presence of distant metastatic disease (except patients with lymphoma).~* Life expectancy less than 6 months~* Patient lives in skilled nursing facility, chronic care facility, nursing home, or palliative care or hospice facility~* Unable to walk~* Presence of significant cancer disease burden that would make patient unlikely to tolerate cardiac rehabilitation (CR)~* Diagnosis of primary cervical esophageal cancer.~* Presence of unstable angina.~* Recipient of heart transplant.~* Patient on cardiac transplant list or has a ventricular assist device~* Patient's baseline weight \> 300 lbs (due to weight limitations of the scale and bioelectrical impedance device)~* Pregnant and/or breastfeeding. Women of childbearing potential must have a negative pregnancy test within 14 days of study entry.~* Other medical comorbidities that make the patient unable to participate in the CR program or other assessments involved with this study.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Home-based cardiac rehabilitation (Type: EXPERIMENTAL): * The intervention consists of a prescribed course of home-based cardiac rehabilitation: 36 sessions, three times a week, one hour each, over a period of 12 weeks.~* Each customized exercise session includes three phases:~  * a 5- to 10-minute warm-up which consists of stretching, flexibility movements, and aerobic activity which gradually raises the heart rate to the desired level~ * a conditioning or training phase, which consists of 20 to 45 minutes of continuous or discontinuous aerobic activity~ * a cool down for 5 to 10 minutes consisting of low-intensity exercise that permits a gradual recovery from the conditioning phase~* The patient will complete a brief questionnaire on the teleHeart application after completing each exercise session on how well they tolerated the exercise. The patient's CR team will receive daily updates from the patient's teleHeart application. Based on feedback from the application, the CR team may modify the patient's exercise program going forward.

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: terminate
termination_type: lack of efficacy